Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN56769820
ISRCTN56769820
Completed
N/A

A comparative study between oxybutynin and botulinum toxin type A in patients with neurogenic detrusor overactivity: urodynamic response and impact of treatment on quality of life: a randomised trial

Dr Henrique Santillo Rehabilitation Center (Brazil)0 sites68 target enrollmentJune 13, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Henrique Santillo Rehabilitation Center (Brazil)
Enrollment
68
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2011
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Henrique Santillo Rehabilitation Center (Brazil)

Eligibility Criteria

Inclusion Criteria

  • •1\. Male and female patients
  • •2\. Over 18 years of age
  • •3\. Patients who have had an SCI for at least 12 months
  • •4\. Patients who have been regularly undergoing intermittent catheterisation

Exclusion Criteria

  • •1\. Pregnancy
  • •2\. A desire to become pregnant during the study period
  • •3\. Breastfeeding
  • •4\. The use of anticoagulants or a report of a blood coagulation disorder
  • •5\. Neuromuscular transmission disorder
  • •6\. The use of any intravesical pharmacologic agents
  • •7\. Previous use of BoNTA

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
A randomised trial comparing the effectiveness of oxybutynin and mirabegron in reducing symptoms of frequency and urgency in patients with benign prostatic hyperplasia receiving medical treatment with tamsulosin.Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
CTRI/2019/10/021513JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH96
Completed
Phase 3
Assessing the effectiveness of oxybutynin and phenazopyridine and celecoxib in reducing complications in the treatment of bladder tumors.Malignant neoplasm of bladder.Malignant neoplasm of bladder
IRCT20171225038070N1Iran University of Medical Sciences120
Completed
Phase 4
Comparison of the Effectiveness of 10% Oxybutynin Topical Gel and 20% Aluminum Chloride in Patients with Primary Hyperhidrosis: a Randomized Double-Blind Controlled Trial
IRCT20221110056463N2Kerman University of Medical Sciences30
Completed
N/A
A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor OveractivitySpinal Cord Injury
NCT01477736Centro de Reabilitação e Readaptação Dr. Henrique Santillo68
Not Yet Recruiting
Phase 3
To study the role of Oxybutinin in infants affected with posterior urethral valveHealth Condition 1: Q642- Congenital posterior urethral valves
CTRI/2023/08/056095Josy Thomas